Zobrazeno 1 - 10
of 121
pro vyhledávání: '"Joanne M, Hilden"'
Autor:
Blaine W. Robinson, John A. Kairalla, Meenakshi Devidas, Andrew J. Carroll, Richard C. Harvey, Nyla A. Heerema, Cheryl L. Willman, Amanda R. Ball, Elliot C. Woods, Nancy C. Ballantyne, Karen A. Urtishak, Frederick G. Behm, Gregory H. Reaman, Joanne M. Hilden, Bruce M. Camitta, Naomi J. Winick, Jeanette Pullen, William L. Carroll, Stephen P. Hunger, ZoAnn E. Dreyer, Carolyn A. Felix
Publikováno v:
Haematologica, Vol 108, Iss 10 (2023)
Externí odkaz:
https://doaj.org/article/a81f0f0ee683429b9b3345bbb4014ff4
Autor:
Erin M. Guest, John A. Kairalla, Joanne M. Hilden, ZoAnn E. Dreyer, Andrew J. Carroll, Nyla A. Heerema, Cindy Y. Wang, Meenakshi Devidas, Lia Gore, Wanda L. Salzer, Naomi J. Winick, William L. Carroll, Elizabeth A. Raetz, Michael Borowitz, Mignon L. Loh, Stephen P. Hunger, Patrick A. Brown
Publikováno v:
Haematologica, Vol 107, Iss 5 (2022)
Externí odkaz:
https://doaj.org/article/6f75c85ff88943d48d1cd90df26deea7
Autor:
Michael J. Burke, Wanda L. Salzer, Meenakshi Devidas, Yunfeng Dai, Lia Gore, Joanne M. Hilden, Eric Larsen, Karen R. Rabin, Patrick A. Zweidler-McKay, Michael J. Borowitz, Brent Wood, Nyla A. Heerema, Andrew J. Carroll, Naomi Winick, William L. Carroll, Elizabeth A. Raetz, Mignon L. Loh, Stephen P. Hunger
Publikováno v:
Haematologica, Vol 104, Iss 5 (2019)
With modern chemotherapy, approximately 90% of patients with pediatric acute lymphoblastic leukemia are now cured. However, subsets of patients can be identified who remain at very high risk of relapse with expected 4-year disease-free survival rates
Externí odkaz:
https://doaj.org/article/400df5614bb0423c96a66827ab493ef8
Autor:
Bryan T Nycz, Samuel R Dominguez, Deborah Friedman, Joanne M Hilden, Diana Ir, Charles E Robertson, Daniel N Frank
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0191232 (2018)
Bloodstream infections (BSI) and Clostridium difficile infections (CDI) in pediatric oncology/hematology/bone marrow transplant (BMT) populations are associated with significant morbidity and mortality. The objective of this study was to explore poss
Externí odkaz:
https://doaj.org/article/a4b8eda56ca54746bc4f9f89ea08e9d0
Autor:
Bryan T Nycz, Samuel R Dominguez, Deborah Friedman, Joanne M Hilden, Diana Ir, Charles E Robertson, Daniel N Frank
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0197530 (2018)
[This corrects the article DOI: 10.1371/journal.pone.0191232.].
Externí odkaz:
https://doaj.org/article/174ca2aec395417aafa009a8f890d0f6
Autor:
Erin M, Guest, John A, Kairalla, Joanne M, Hilden, ZoAnn E, Dreyer, Andrew J, Carroll, Nyla A, Heerema, Cindy Y, Wang, Meenakshi, Devidas, Lia, Gore, Wanda L, Salzer, Naomi J, Winick, William L, Carroll, Elizabeth A, Raetz, Michael, Borowitz, Mignon L, Loh, Stephen P, Hunger, Patrick A, Brown
Publikováno v:
Haematologica. 107(5)
Autor:
Lindsey Hoffman, Jamie M Fleming, David A. Mong, Rebecca L Coughlin, Kelly W. Maloney, Joanne M. Hilden, Savannah Ross, Timothy M. Crombleholme, Gee Mei Tan
Publikováno v:
Paediatric anaesthesiaREFERENCES. 31(8)
Background Mediastinal masses in children may present with compression of the great vessels and airway. An interdisciplinary plan for rapid diagnosis, acute management, and treatment prevents devastating outcomes and optimizes care. Emergency pretrea
Autor:
Nyla A. Heerema, William L. Carroll, Eric Larsen, Mignon L. Loh, Joanne M. Hilden, Naomi J. Winick, Michael J. Burke, Wanda L. Salzer, Michael J. Borowitz, Karen R. Rabin, Meenakshi Devidas, Yunfeng Dai, Stephen P. Hunger, Andrew J. Carroll, Patrick A. Zweidler-McKay, Brent L. Wood, Lia Gore, Elizabeth A. Raetz
Publikováno v:
Haematologica, vol 104, iss 5
Haematologica
Haematologica
With modern chemotherapy, approximately 90% of patients with pediatric acute lymphoblastic leukemia are now cured. However, subsets of patients can be identified who remain at very high risk of relapse with expected 4-year disease-free survival rates
Autor:
Carolyn A. Felix, Patrizia Porazzi, Joanne M. Hilden, James W Davenport, Sarah K. Tasian, Meenakshi Devidas, ZoAnn E. Dreyer, Shenghao Jin, I-Ming L. Chen, Alix E. Seif, Tiffaney Vincent, Andrew J. Carroll, Martin Carroll, Blaine W. Robinson, Karen A. Urtishak, David T. Teachey, Katherine L. B. Borden, Biljana Culjkovic-Kraljacic, Stephen P. Hunger, Li-San Wang, Jeffrey S. Barrett, Jonni S. Moore, Richard C. Harvey, Nyla A. Heerema, Cheryl L. Willman
Publikováno v:
Oncogene
The poor outcomes in infant acute lymphoblastic leukemia (ALL) necessitate new treatments. Here we discover that EIF4E protein is elevated in most cases of infant ALL and test EIF4E targeting by the repurposed antiviral agent ribavirin, which has ant
Autor:
Joanne M. Hilden, Mignon L. Loh, Stephen P. Hunger, Lia Gore, Elizabeth A. Raetz, Naomi J. Winick, William L. Carroll, Donald Small, John A. Kairalla, Cindy Wang, Wanda L. Salzer, Nyla A. Heerema, Zo Ann E. Dreyer, Meenakshi Devidas, Michael J. Borowitz, Andrew J. Carroll, Patrick A. Brown
Publikováno v:
Leukemia
Infants with KMT2A‐rearranged acute lymphoblastic leukemia (KMT2A-r ALL) have a poor prognosis. KMT2A-r ALL overexpresses FLT3, and the FLT3 inhibitor (FLT3i) lestaurtinib potentiates chemotherapy‐induced cytotoxicity in preclinical models. Child
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::936bfdc962c0b2ff7a0463ffafe7612c
https://europepmc.org/articles/PMC8763141/
https://europepmc.org/articles/PMC8763141/